{
  "question_stem": {
    "en": "A 56-year-old woman comes to clinic for follow-up of heart failure with reduced ejection fraction. Over the last 3 months, the patient has been hospitalized twice due to acute decompensation of heart failure that required treatment with intravenous furosemide. Since her most recent discharge, she has been taking high doses of oral furosemide, but she continues to have progressive lower extremity edema and weight gain. Serum creatinine is 1.2 mg/dL and serum potassium is 4.1 mEq/L. The patient is started on metolazone. The addition of metolazone is likely to assist in treating this patient because of which of the following effects of furosemide?",
    "zh": "一名56岁的女性因射血分数降低的心力衰竭随访而来就诊。在过去的3个月里，该患者因心力衰竭急性失代偿住院两次，需要静脉注射呋塞米治疗。自从最近一次出院以来，她一直在服用大剂量的口服呋塞米，但她仍然有进行性下肢水肿和体重增加。血清肌酐为1.2 mg/dL，血清钾为4.1 mEq/L。患者开始服用美托拉宗。由于呋塞米的下列哪种作用，加入美托拉宗可能有助于治疗该患者？"
  },
  "question": {
    "en": "The addition of metolazone is likely to assist in treating this patient because of which of the following effects of furosemide?",
    "zh": "由于呋塞米的下列哪种作用，加入美托拉宗可能有助于治疗该患者？"
  },
  "options": {
    "A": {
      "en": "Increased calcium delivery to the distal tubules",
      "zh": "增加钙输送到远端小管"
    },
    "B": {
      "en": "Increased sodium delivery to the distal tubules",
      "zh": "增加钠输送到远端小管"
    },
    "C": {
      "en": "Increased tubular reabsorption of bicarbonate",
      "zh": "增加小管对碳酸氢盐的重吸收"
    },
    "D": {
      "en": "Increased tubular reabsorption of uric acid",
      "zh": "增加小管对尿酸的重吸收"
    },
    "E": {
      "en": "Reduced tubular reabsorption of glucose",
      "zh": "减少小管对葡萄糖的重吸收"
    },
    "F": {
      "en": "Reduced tubular reabsorption of potassium",
      "zh": "减少小管对钾的重吸收"
    }
  },
  "correct_answer": "B",
  "explanation": {
    "en": "This patient has decompensated heart failure with ongoing volume retention despite high doses of oral furosemide (ie, loop diuretic) therapy. Thiazide diuretics, especially metolazone, potentiate the diuretic effect of loop diuretics and can be helpful in treating refractory volume overload. {{exhibit_1}}\n\nSodium is the major determinant of volume status. Loop diuretics function by inhibiting the Na-K-2Cl cotransporter in the ascending limb of the loop of Henle to block sodium absorption and encourage the excretion of sodium and water in the urine. However, the sodium excretion caused by loop diuretics is limited by the reabsorption of sodium in the distal convoluted tubule; the Na-Cl cotransporter in the distal tubule counteracts some of the effect of loop diuretics by absorbing much of the sodium that is not absorbed in the loop of Henle. Inhibition of the Na-Cl cotransporter with metolazone prevents reabsorption of the increased sodium delivered to the distal tubule, significantly increasing total sodium excretion.\n\n(Choice A) Loop diuretics inhibit calcium absorption in the loop of Henle, leading to increased calcium delivery to the distal tubule. However, calcium has minimal effect on volume status. Thiazide diuretics increase calcium absorption in the distal tubule, making up for some of the calcium loss caused by loop diuretics.\n\n(Choice C) Loop diuretics stimulate hydrogen ion excretion and bicarbonate reabsorption, creating a tendency toward metabolic alkalosis. Carbonic anhydrase inhibitors (eg, acetazolamide) block bicarbonate absorption in the proximal tubule and are sometimes used to minimize the metabolic alkalosis caused by loop diuretics.\n\n(Choice D) Both loop and thiazide diuretics increase the reabsorption of uric acid and, therefore, may increase the risk of gout attacks.\n\n(Choice E) Both loop and thiazide diuretics have minimal effect on tubular glucose reabsorption. Sodium-glucose cotransporter-2 inhibitors (eg, empagliflozin) block glucose resorption in the proximal tubule to lower serum glucose levels while also stimulating an osmotic diuresis.\n\n(Choice F) The increased distal tubular delivery of sodium caused by loop diuretics stimulates increased potassium secretion by the principal cells in the late distal tubule and collecting duct. This potassium loss is amplified with the addition of a thiazide diuretic. Potassium-sparing diuretics (eg, spironolactone) can help offset the potassium loss caused by loop and thiazide diuretics.\n\nEducational objective:\nThiazide diuretics, especially metolazone, potentiate the diuretic effect of loop diuretics (eg, furosemide) by blocking the reabsorption of the increased distal tubular sodium delivery caused by loop diuretics.",
    "zh": "该患者在口服大剂量呋塞米（即，袢利尿剂）治疗的情况下，仍有心力衰竭失代偿，并持续存在容量潴留。噻嗪类利尿剂，特别是美托拉宗，可增强袢利尿剂的利尿作用，并且有助于治疗难治性容量超负荷。{{exhibit_1}}\n\n钠是决定血容量的主要因素。袢利尿剂通过抑制亨利袢升支中的Na-K-2Cl协同转运蛋白，从而阻断钠的吸收，并促进尿液中钠和水的排泄。然而，袢利尿剂引起的钠排泄受到远曲小管中钠重吸收的限制；远曲小管中的Na-Cl协同转运蛋白通过吸收亨利袢中未被吸收的大部分钠来抵消部分袢利尿剂的作用。使用美托拉宗抑制Na-Cl协同转运蛋白可防止输送到远曲小管的钠的重吸收，从而显著增加钠的总排泄量。\n\n(选项 A) 袢利尿剂抑制亨利袢中的钙吸收，导致更多的钙输送到远曲小管。然而，钙对血容量的影响很小。噻嗪类利尿剂增加远曲小管中的钙吸收，弥补了袢利尿剂引起的部分钙流失。\n\n(选项 C) 袢利尿剂刺激氢离子排泄和碳酸氢盐重吸收，从而产生代谢性碱中毒的趋势。碳酸酐酶抑制剂（如乙酰唑胺）阻断近端小管中的碳酸氢盐吸收，有时用于最大程度地减少袢利尿剂引起代谢性碱中毒。\n\n(选项 D) 袢利尿剂和噻嗪类利尿剂均增加尿酸的重吸收，因此，可能会增加痛风发作的风险。\n\n(选项 E) 袢利尿剂和噻嗪类利尿剂对小管葡萄糖重吸收的影响很小。钠-葡萄糖协同转运蛋白-2抑制剂（如恩帕列净）阻断近端小管中的葡萄糖重吸收，从而降低血清葡萄糖水平，同时刺激渗透性利尿。\n\n(选项 F) 袢利尿剂引起的远端小管钠输送增加刺激了晚期远端小管和集合管中主细胞增加钾的分泌。噻嗪类利尿剂的加入会放大这种钾的流失。保钾利尿剂（如螺内酯）可以帮助抵消袢利尿剂和噻嗪类利尿剂引起的钾流失。\n\n教学目的：\n噻嗪类利尿剂，特别是美托拉宗，通过阻断袢利尿剂引起的远端小管钠输送增加的重吸收，从而增强袢利尿剂（如呋塞米）的利尿作用。"
  },
  "summary": {
    "en": "This question tests knowledge of diuretic mechanisms, specifically how thiazide diuretics potentiate the effects of loop diuretics in treating volume overload in heart failure. It requires understanding of sodium handling in different nephron segments. \n\nThe key to solving this question is recognizing that loop diuretics increase sodium delivery to the distal tubule, and thiazides block sodium reabsorption in the distal tubule. Combining these medications results in increased sodium excretion and improved diuresis.",
    "zh": "本题考察对利尿剂机制的了解，特别是噻嗪类利尿剂如何增强袢利尿剂治疗心力衰竭容量超负荷的作用。它需要理解不同肾单位段的钠处理方式。\n\n解决本题的关键是认识到袢利尿剂增加钠向远端小管的输送，而噻嗪类利尿剂阻断远端小管中的钠重吸收。将这些药物联合使用可增加钠的排泄并改善利尿。"
  },
  "tags": "Heart failure; Diuretics; Loop diuretics; Thiazide diuretics; Metolazone; Furosemide; Sodium reabsorption; Volume overload; Nephrology; Electrolyte balance",
  "category": "CVS",
  "question_id": "18639",
  "has_exhibits": true,
  "exhibit_count": 1,
  "exhibit_files": [
    "image1.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\CVS 23\\18639",
  "extracted_at": "2025-11-05T12:04:10.478810",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T16:53:20.828889",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}